The European Molecular Biology Organization (EMBO) announced today (September 30) linkurl:the appointment;http://www.embo.org/news/maria-leptin-appointed-next-director-of-embo.html of a new president: Maria Leptin, a developmental biologist at the University of Cologne, Germany. Maria LeptinImage: EMBOLeptin will be the first woman appointed to the position, and takes over from Herman Bujard, the director since 2007, who is stepping down to devote more time to his research on malaria and gen
 |
Image: EMBO |
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.
